サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：関節リウマチの世界市場 - 市場シェア、規模、動向、業界分析：治療法別、流通チャネル別、薬剤タイプ別、地域別、セグメント予測（2022年～2030年）
市場調査レポート
商品コード
1150074

関節リウマチの世界市場 - 市場シェア、規模、動向、業界分析：治療法別、流通チャネル別、薬剤タイプ別、地域別、セグメント予測（2022年～2030年）

Rheumatoid Arthritis Market Share, Size, Trends, Industry Analysis Report, By Therapy (Cell Therapy, DMARD, Symptomatic Treatment, Intermediate Corticosteroid Therapies); By Distribution Channel; By Drug Type; By Region; Segment Forecast, 2022 - 2030
出版日: | 発行: Polaris Market Research | ページ情報: 英文 117 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.98円
関節リウマチの世界市場 - 市場シェア、規模、動向、業界分析：治療法別、流通チャネル別、薬剤タイプ別、地域別、セグメント予測（2022年～2030年）
出版日: 2022年10月01日
発行: Polaris Market Research
ページ情報: 英文 117 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の関節リウマチの市場規模は、2030年までに333億米ドルに達すると予測されています。

当レポートでは、世界の関節リウマチ市場について調査分析し、市場力学、セグメント分析、地域分析、企業プロファイルなど、体系的な情報を提供しています。

目次

第1章 イントロダクション

  • レポート説明
    • 調査目的
    • 市場範囲
    • 前提条件
  • ステークホルダー

第2章 エグゼクティブサマリー

  • 市場のハイライト

第3章 調査手法

  • 概要
    • データマイニング
  • データソース
    • 一次ソース
    • 二次ソース

第4章 世界の関節リウマチ市場の洞察

  • 関節リウマチ：業界のスナップショット
  • 関節リウマチ市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーターのファイブフォース分析
    • 供給企業の交渉力（中）
    • 新規参入者の脅威（低）
    • 買い手の交渉力（中）
    • 代替品の脅威（中）
    • 既存企業間の競争力（高）
  • PESTEL分析
  • 関節リウマチ市場の業界動向
  • バリューチェーン分析
  • COVID-19影響分析

第5章 世界の関節リウマチ市場：薬剤タイプ別

  • 主要な調査結果
  • イントロダクション
    • 薬剤タイプ別：2018年～2030年
  • 医薬品
    • 医薬品別、地域別：2018年～2030年
  • NSAID
    • NSAID別、地域別：2018年～2030年
  • 鎮痛剤
    • 鎮痛剤別、地域別：2018年～2030年
  • DMARD
    • DMARD別、地域別：2018年～2030年
  • グルココルチコイド
    • グルココルチコイド別、地域別：2018年～2030年
  • バイオ医薬品
    • バイオ医薬品別、地域別：2018年～2030年
  • 生物製剤
    • 生物製剤別、地域別：2018年～2030年
  • バイオシミラー
    • バイオシミラー別、地域別：2018年～2030年

第6章 世界の関節リウマチ市場：流通チャネル別

  • 主要な調査結果
  • イントロダクション
    • 流通チャネル別：2018年～2030年
  • 院内薬局
    • 院内薬局別、地域別：2018年～2030年
  • 小売薬局
    • 小売薬局別、地域別：2018年～2030年
  • ドラッグストア
    • ドラッグストア別、地域別：2018年～2030年

第7章 世界の関節リウマチ市場：治療法別

  • 主要な調査結果
  • イントロダクション
    • 治療法別：2018年～2030年
  • 対症療法
    • 対症療法別、地域別：2018年～2030年
  • 中間コルチコステロイド療法
    • 中間コルチコステロイド療法別、地域別：2018年～2030年
  • 幹細胞療法/細胞療法
    • 幹細胞療法/細胞療法別、地域別：2018年～2030年
  • 疾患修飾性抗リウマチ薬（DMARD）
    • 疾患修飾性抗リウマチ薬（DMARD）別、地域別：2018年～2030年
  • 従来型DMARD
    • 従来型DMARD別、地域別：2018年～2030年
  • 生物学的DMARD
    • 生物学的DMARD別、地域別：2018年～2030年

第8章 世界の関節リウマチ市場：地域別

  • 主要な調査結果
  • イントロダクション
    • 関節リウマチ市場評価 - 地域別：2018年～2030年
  • 北米
    • 薬剤タイプ別：2018年～2030年
    • 治療法別：2018年～2030年
    • 流通チャネル別：2018年～2030年
    • 米国
    • カナダ
  • 欧州
    • 薬剤タイプ別：2018年～2030年
    • 治療法別：2018年～2030年
    • 流通チャネル別：2018年～2030年
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • オランダ
    • ロシア
  • アジア太平洋
    • 薬剤タイプ別：2018年～2030年
    • 治療法別：2018年～2030年
    • 流通チャネル別：2018年～2030年
    • 中国
    • インド
    • マレーシア
    • 日本
    • インドネシア
    • 韓国
  • 中東・アフリカ
    • 薬剤タイプ別：2018年～2030年
    • 治療法別：2018年～2030年
    • 流通チャネル別：2018年～2030年
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
  • ラテンアメリカ
    • 薬剤タイプ別：2018年～2030年
    • 治療法別：2018年～2030年
    • 流通チャネル別：2018年～2030年
    • メキシコ
    • ブラジル
    • アルゼンチン

第9章 競合情勢

  • 事業拡張と買収の分析
    • 事業拡張
    • 買収
  • 提携/協業/協定/展示会

第10章 企業プロファイル

  • AbbVie Incorporation
  • Amgen Corporation
  • Amneal Pharmaceuticals LLC
  • Bristol-Myers Squibb Company
  • Cipla, Inc
  • Dr. Reddy's Laboratories
  • Norbrook Laboratories Ltd
  • Roxane Laboratories Inc
  • Pfizer Inc
  • Sanofi SA
  • Sun Pharmaceutical Industries Ltd
  • Sobi Inc
  • Teva Pharmaceuticals, Inc
図表

List of Tables

  • Table 1 Global Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
  • Table 2 Global Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 3 Global Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 4 Rheumatoid Arthritis Market Assessment, By Geography, 2018 - 2030 (USD Billion)
  • Table 5 North America: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
  • Table 6 North America: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 7 North America: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 8 U.S.: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
  • Table 9 U.S.: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 10 U.S.: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 11 Canada: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
  • Table 12 Canada: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 13 Canada: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 14 Europe: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
  • Table 15 Europe: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 16 Europe: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 17 UK: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
  • Table 18 UK: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 19 UK: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 20 France: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
  • Table 21 France: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 22 France: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 23 Germany: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
  • Table 24 Germany: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 25 Germany: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 26 Italy: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
  • Table 27 Italy: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 28 Italy: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 29 Spain: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
  • Table 30 Spain: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 31 Spain: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 32 Netherlands: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
  • Table 33 Netherlands: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 34 Netherlands: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 35 Russia: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
  • Table 36 Russia: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 37 Russia: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 38 Asia Pacific: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
  • Table 39 Asia Pacific: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 40 Asia Pacific: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 41 China: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
  • Table 42 China: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 43 China: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 44 India: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
  • Table 45 India: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 46 India: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 47 Malaysia: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
  • Table 48 Malaysia: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 49 Malaysia: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 50 Japan: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
  • Table 51 Japan: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 52 Japan: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 53 Indonesia: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
  • Table 54 Indonesia: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 55 Indonesia: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 56 South Korea: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
  • Table 57 South Korea: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 58 South Korea: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 59 Middle East & Africa: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
  • Table 60 Middle East & Africa: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 61 Middle East & Africa: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 62 Saudi Arabia: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
  • Table 63 Saudi Arabia: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 64 Saudi Arabia: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 65 UAE: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
  • Table 66 UAE: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 67 UAE: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 68 Israel: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
  • Table 69 Israel: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 70 Israel: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 71 South Africa: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
  • Table 72 South Africa: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 73 South Africa: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 74 Latin America: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
  • Table 75 Latin America: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 76 Latin America: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 77 Mexico: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
  • Table 78 Mexico: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 79 Mexico: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 80 Brazil: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
  • Table 81 Brazil: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 82 Brazil: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 83 Argentina: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
  • Table 84 Argentina: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 85 Argentina: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)

List of Figures

Figure 1. Global Rheumatoid Arthritis Market, 2018 - 2030 (USD Billion)

Figure 2. Integrated Ecosystem

Figure 3. Research Methodology: Top-Down & Bottom-Up Approach

Figure 4. Market by Geography

Figure 5. Porter's Five Forces

Figure 6. Market by Distribution Channel

Figure 7. Global Rheumatoid Arthritis Market, by Distribution Channel, 2021 & 2030 (USD Billion)

Figure 8. Market by Drug Type

Figure 9. Global Rheumatoid Arthritis Market, by Drug Type, 2021 & 2030 (USD Billion)

Figure 10. Market by Therapy

Figure 11. Global Rheumatoid Arthritis Market, by Therapy, 2021 & 2030 (USD Billion)

Figure 12. Rheumatoid Arthritis Market Assessment, By Geography, 2018 - 2030 (USD Billion)

Figure 13. Strategic Analysis - Rheumatoid Arthritis Market

目次
Product Code: PM1371

The global rheumatoid arthritis market size is expected to reach USD 33.30 billion by 2030, according to a new study by Polaris Market Research. The report "Rheumatoid Arthritis Market Share, Size, Trends, Industry Analysis Report, By Therapy (Cell Therapy, DMARD, Symptomatic Treatment, Intermediate Corticosteroid Therapies); By Distribution Channel; By Drug Type; By Region; Segment Forecast, 2022 - 2030" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The market is being fueled by a rise in the number of arthritis and associated joint problems. Rheumatoid arthritis is on the rise as a result of the shift to an unhealthy lifestyle, rising metabolic disorders & age, family history of joint diseases, and increased obesity. As per the Centers for Disease Control and Prevention (CDC), millions of people in the US have severe pain due to arthritis each year. 15 million adults with arthritis report having severe joint pain as a result of their disease.

To strengthen their position in this market, manufacturers are concentrating on partnerships with other competitors. In January 2022, the Queen Mary University of London and Exagen Inc. announced a partnership and exclusive license agreement. The collaboration's main goal is to customize the choice of treatment agents for Rheumatoid Arthritis (RA) patients by developing and refining patent-pending personalized medicine techniques based on RNA expression patterns.

Both parties will work together to develop the patent-pending assays, which will eventually lead to the commercialization of cutting-edge molecular assays that divide patients into groups based on the expression of particular genes in synovial tissue biopsies. Thus, these factors are assisting the market growth over the forecast period.

Furthermore, in comparison to the general population, women have a higher risk of developing certain autoimmune illnesses. For instance, as per the Department of Health & Human Services (HHS) in the US, RA is the fourth-largest cause of disability among women in the US and are the eighth-leading cause of mortality for women between the ages of 15 and 64. The prevalence of rheumatoid arthritis (RA) in the US is high due to which the demand and adoption of treatment have increased. In rheumatoid arthritis (RA), the immune system attacks the joint.

The development of complex biologics, rising purchasing power, rising healthcare costs, and improved accessibility to high-quality medicines for middle-class and low-income families globally are all important causes. On the other hand, the global market is anticipated to grow swiftly and change the market picture due to improved treatment for early treatment and screening of rheumatoid arthritis. As a result, the global market for rheumatoid arthritis medications is seeing rapid growth, which is opening up attractive potential.

Rheumatoid Arthritis Market Report Highlights

The online pharmacy segment is anticipated to grow at a significant CAGR over the forecast period. This can be attributed to the expanding e-commerce market and rising popularity of online drug sales following the COVID-19 virus spread. The growing use of smartphones and the internet is helping the segmental expansion even further.

NSAIDs drug segment accounted for a major share of the global revenue share. Non-steroidal anti-inflammatory drugs (NSAIDs) are among them and are frequently used to treat the symptoms of rheumatic disorders, which are characterized by a variety of acute pain symptoms and long-term musculoskeletal discomfort. These medications' main result is to lessen acute inflammation, which lessens pain and enhances overall performance.

Asia Pacific is expected to grow at a highest CAGR over the projected period. Due to the substantial population base vulnerable to RA, the growth of the R&D sector, and the rising adoption of RA drugs, the region offers profitable positions for major players operating in the market

The global market players with a global presence includes AbbVie Incorporation, Sun Pharmaceutical Industries Ltd., Sobi Inc., and Teva Pharmaceuticals, Inc.

Polaris Market Research has segmented the rheumatoid arthritis market report based on drug type, distribution channel, therapy, and region:

Rheumatoid Arthritis, Therapy Outlook (Revenue - USD Billion, 2018 - 2030)

Symptomatic Treatment

Intermediate Corticosteroid Therapies

Stem Cell Therapy/ Cell Therapy

Disease Modifying Anti-rheumatic Drug (DMARD)

Conventional DMARDs

Biological DMARDs

Rheumatoid Arthritis, Distribution Channel Outlook (Revenue - USD Billion, 2018 - 2030)

Hospital Pharmacies

Retail Pharmacies

Drug Stores

Rheumatoid Arthritis, Drug Type Outlook (Revenue - USD Billion, 2018 - 2030)

Pharmaceuticals

NSAIDs

Analgesics

DMARDs

Glucocorticoids

Biopharmaceuticals

Biologics

Biosimilars

Rheumatoid Arthritis, Regional Outlook (Revenue - USD Billion, 2018 - 2030)

North America

U.S

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Rheumatoid Arthritis Market Insights

  • 4.1. Rheumatoid Arthritis - Industry Snapshot
  • 4.2. Rheumatoid Arthritis Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising FDA approvals for the treatment of rheumatoid arthritis
      • 4.2.1.2. Increase in healthcare expenditure worldwide
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Lack of access to treatment of rheumatoid arthritis in underdeveloped countries
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Rheumatoid Arthritis Market Industry Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Rheumatoid Arthritis Market, by Drug Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
  • 5.3. Pharmaceuticals
    • 5.3.1. Global Rheumatoid Arthritis Market, by Pharmaceuticals, by Region, 2018 - 2030 (USD Billion)
  • 5.4. NSAIDs
    • 5.4.1. Global Rheumatoid Arthritis Market, by NSAIDs, by Region, 2018 - 2030 (USD Billion)
  • 5.5. Analgesics
    • 5.5.1. Global Rheumatoid Arthritis Market, by Analgesics, by Region, 2018 - 2030 (USD Billion)
  • 5.6. DMARDs
    • 5.6.1. Global Rheumatoid Arthritis Market, by DMARDs, by Region, 2018 - 2030 (USD Billion)
  • 5.7. Glucocorticoids
    • 5.7.1. Global Rheumatoid Arthritis Market, by Glucocorticoids, by Region, 2018 - 2030 (USD Billion)
  • 5.8. Biopharmaceuticals
    • 5.8.1. Global Rheumatoid Arthritis Market, by Biopharmaceuticals, by Region, 2018 - 2030 (USD Billion)
  • 5.9. Biologics
    • 5.9.1. Global Rheumatoid Arthritis Market, by Biologics, by Region, 2018 - 2030 (USD Billion)
  • 5.10. Biosimilars
    • 5.10.1. Global Rheumatoid Arthritis Market, by Biosimilars, by Region, 2018 - 2030 (USD Billion)

6. Global Rheumatoid Arthritis Market, by Distribution Channel

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • 6.3. Hospital Pharmacies
    • 6.3.1. Global Rheumatoid Arthritis Market, by Hospital Pharmacies, by Region, 2018 - 2030 (USD Billion)
  • 6.4. Retail Pharmacies
    • 6.4.1. Global Rheumatoid Arthritis Market, by Retail Pharmacies, by Region, 2018 - 2030 (USD Billion)
  • 6.5. Drug Stores
    • 6.5.1. Global Rheumatoid Arthritis Market, by Drug Stores, by Region, 2018 - 2030 (USD Billion)

7. Global Rheumatoid Arthritis Market, by Therapy

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
  • 7.3. Symptomatic Treatment
    • 7.3.1. Global Rheumatoid Arthritis Market, by Symptomatic Treatment, by Region, 2018 - 2030 (USD Billion)
  • 7.4. Intermediate Corticosteroid Therapies
    • 7.4.1. Global Rheumatoid Arthritis Market, by Intermediate Corticosteroid Therapies, by Region, 2018 - 2030 (USD Billion)
  • 7.5. Stem Cell Therapy/ Cell Therapy
    • 7.5.1. Global Rheumatoid Arthritis Market, by Stem Cell Therapy/ Cell Therapy, by Region, 2018 - 2030 (USD Billion)
  • 7.6. Disease Modifying Anti-rheumatic Drug (DMARD)
    • 7.6.1. Global Rheumatoid Arthritis Market, by Disease Modifying Anti-rheumatic Drug (DMARD), by Region, 2018 - 2030 (USD Billion)
  • 7.7. Conventional DMARDs
    • 7.7.1. Global Rheumatoid Arthritis Market, by Conventional DMARDs, by Region, 2018 - 2030 (USD Billion)
  • 7.8. Biological DMARDs
    • 7.8.1. Global Rheumatoid Arthritis Market, by Biological DMARDs, by Region, 2018 - 2030 (USD Billion)

8. Global Rheumatoid Arthritis Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Rheumatoid Arthritis Market Assessment, By Geography, 2018 - 2030 (USD Billion)
  • 8.3. Rheumatoid Arthritis Market - North America
    • 8.3.1. North America: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
    • 8.3.2. North America: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
    • 8.3.3. North America: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
    • 8.3.4. Rheumatoid Arthritis Market - U.S.
      • 8.3.4.1. U.S.: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
      • 8.3.4.2. U.S.: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
      • 8.3.4.3. U.S.: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
    • 8.3.5. Rheumatoid Arthritis Market - Canada
      • 8.3.5.1. Canada: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
      • 8.3.5.2. Canada.: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
      • 8.3.5.3. Canada: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • 8.4. Rheumatoid Arthritis Market - Europe
    • 8.4.1. Europe: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
    • 8.4.2. Europe.: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
    • 8.4.3. Europe: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
    • 8.4.4. Rheumatoid Arthritis Market - UK
      • 8.4.4.1. UK: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
      • 8.4.4.2. UK.: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
      • 8.4.4.3. UK: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
    • 8.4.5. Rheumatoid Arthritis Market - France
      • 8.4.5.1. France: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
      • 8.4.5.2. France.: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
      • 8.4.5.3. France: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
    • 8.4.6. Rheumatoid Arthritis Market - Germany
      • 8.4.6.1. Germany: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
      • 8.4.6.2. Germany.: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
      • 8.4.6.3. Germany: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
    • 8.4.7. Rheumatoid Arthritis Market - Italy
      • 8.4.7.1. Italy: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
      • 8.4.7.2. Italy.: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
      • 8.4.7.3. Italy: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
    • 8.4.8. Rheumatoid Arthritis Market - Spain
      • 8.4.8.1. Spain: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
      • 8.4.8.2. Spain.: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
      • 8.4.8.3. Spain: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
    • 8.4.9. Rheumatoid Arthritis Market - Netherlands
      • 8.4.9.1. Netherlands: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
      • 8.4.9.2. Netherlands.: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
      • 8.4.9.3. Netherlands: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
    • 8.4.10. Rheumatoid Arthritis Market - Russia
      • 8.4.10.1. Russia: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
      • 8.4.10.2. Russia.: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
      • 8.4.10.3. Russia: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • 8.5. Rheumatoid Arthritis Market - Asia Pacific
    • 8.5.1. Asia Pacific: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
    • 8.5.2. Asia Pacific.: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
    • 8.5.3. Asia Pacific: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
    • 8.5.4. Rheumatoid Arthritis Market - China
      • 8.5.4.1. China: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
      • 8.5.4.2. China.: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
      • 8.5.4.3. China: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
    • 8.5.5. Rheumatoid Arthritis Market - India
      • 8.5.5.1. India: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
      • 8.5.5.2. India.: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
      • 8.5.5.3. India: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
    • 8.5.6. Rheumatoid Arthritis Market - Malaysia
      • 8.5.6.1. Malaysia: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
      • 8.5.6.2. Malaysia.: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
      • 8.5.6.3. Malaysia: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
    • 8.5.7. Rheumatoid Arthritis Market - Japan
      • 8.5.7.1. Japan: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
      • 8.5.7.2. Japan.: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
      • 8.5.7.3. Japan: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
    • 8.5.8. Rheumatoid Arthritis Market - Indonesia
      • 8.5.8.1. Indonesia: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
      • 8.5.8.2. Indonesia.: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
      • 8.5.8.3. Indonesia: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
    • 8.5.9. Rheumatoid Arthritis Market - South Korea
      • 8.5.9.1. South Korea: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
      • 8.5.9.2. South Korea.: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
      • 8.5.9.3. South Korea: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • 8.6. Rheumatoid Arthritis Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
    • 8.6.2. Middle East & Africa.: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
    • 8.6.3. Middle East & Africa: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
    • 8.6.4. Rheumatoid Arthritis Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
    • 8.6.5. Rheumatoid Arthritis Market - UAE
      • 8.6.5.1. UAE: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
      • 8.6.5.2. UAE.: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
      • 8.6.5.3. UAE: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
    • 8.6.6. Rheumatoid Arthritis Market - Israel
      • 8.6.6.1. Israel: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
      • 8.6.6.2. Israel.: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
      • 8.6.6.3. Israel: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
    • 8.6.7. Rheumatoid Arthritis Market - South Africa
      • 8.6.7.1. South Africa: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
      • 8.6.7.2. South Africa.: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
      • 8.6.7.3. South Africa: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • 8.7. Rheumatoid Arthritis Market - Latin America
    • 8.7.1. Latin America: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
    • 8.7.2. Latin America.: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
    • 8.7.3. Latin America: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
    • 8.7.4. Rheumatoid Arthritis Market - Mexico
      • 8.7.4.1. Mexico: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
      • 8.7.4.2. Mexico.: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
      • 8.7.4.3. Mexico: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
    • 8.7.5. Rheumatoid Arthritis Market - Brazil
      • 8.7.5.1. Brazil: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
      • 8.7.5.2. Brazil.: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
      • 8.7.5.3. Brazil: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
    • 8.7.6. Rheumatoid Arthritis Market - Argentina
      • 8.7.6.1. Argentina: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
      • 8.7.6.2. Argentina.: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
      • 8.7.6.3. Argentina: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. AbbVie Incorporation
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Amgen Corporation
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Amneal Pharmaceuticals LLC
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Bristol-Myers Squibb Company
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Cipla, Inc
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Dr. Reddy's Laboratories
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Norbrook Laboratories Ltd
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Roxane Laboratories Inc
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Pfizer Inc
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Sanofi SA
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Sun Pharmaceutical Industries Ltd
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Sobi Inc
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Teva Pharmaceuticals, Inc
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development